Apr 25 |
Mahesh Krishnan Elected to Halozyme's Board of Directors
|
Apr 24 |
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
|
Apr 23 |
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|
Apr 23 |
Halozyme to Report First Quarter 2024 Financial and Operating Results
|
Apr 18 |
Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
|
Apr 18 |
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
|
Apr 10 |
Halozyme's Strategic Partnerships Fueling Next-Gen Therapeutics
|
Apr 9 |
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
|
Apr 4 |
Halozyme Therapeutics (HALO) is a Top-Ranked Value Stock: Should You Buy?
|
Apr 4 |
Is Now The Time To Put Halozyme Therapeutics (NASDAQ:HALO) On Your Watchlist?
|